The conventional view on Wall Street is that the Medicare formularies mimic commercial formularies, and that's incorrect. These formularies are more stringent than what you see in the private sector.
The whole purpose of this drug benefit was to get drug coverage in the hands of all Medicare beneficiaries. Where are the people? That's the question.